Global Non-Invasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: GE2B06D44DBEEN
QYResearch

Abstracts

This report focuses on the global Non-Invasive Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Invasive Cancer Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Gen-Probe Inc
• Digene Corporation
• Quest Diagnostics Inc
• Cancer, Genetics Inc
• BIOVIEW Inc
• AVIVA Biosciences Corporation
• Laboratory Corporation of America Holdings (LabCorp)
• A&G Pharmaceutical
• Affymetrix Inc
• Precision Therapeutics

Market segment by Type, the product can be split into

• CTCs
• CTNAS
• Exosomes

Market segment by Application, split into

• Blood
• Urine
• Saliva

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Non-Invasive Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Non-Invasive Cancer Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Non-Invasive Cancer Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CTCs
  1.4.3 CTNAS
  1.4.4 Exosomes
1.5 Market by Application
  1.5.1 Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Blood
  1.5.3 Urine
  1.5.4 Saliva
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Non-Invasive Cancer Diagnostics Market Perspective (2015-2026)
2.2 Non-Invasive Cancer Diagnostics Growth Trends by Regions
  2.2.1 Non-Invasive Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Non-Invasive Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Non-Invasive Cancer Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Non-Invasive Cancer Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Non-Invasive Cancer Diagnostics Players by Market Size
  3.1.1 Global Top Non-Invasive Cancer Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio
  3.2.1 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Non-Invasive Cancer Diagnostics Revenue in 2019
3.3 Non-Invasive Cancer Diagnostics Key Players Head office and Area Served
3.4 Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
3.5 Date of Enter into Non-Invasive Cancer Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Non-Invasive Cancer Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 NON-INVASIVE CANCER DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)
5.2 Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Non-Invasive Cancer Diagnostics Market Size (2015-2020)
6.2 Non-Invasive Cancer Diagnostics Key Players in North America (2019-2020)
6.3 North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
6.4 North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Non-Invasive Cancer Diagnostics Market Size (2015-2020)
7.2 Non-Invasive Cancer Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
7.4 Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Non-Invasive Cancer Diagnostics Market Size (2015-2020)
8.2 Non-Invasive Cancer Diagnostics Key Players in China (2019-2020)
8.3 China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
8.4 China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Non-Invasive Cancer Diagnostics Market Size (2015-2020)
9.2 Non-Invasive Cancer Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
9.4 Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Non-Invasive Cancer Diagnostics Market Size (2015-2020)
10.2 Non-Invasive Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Non-Invasive Cancer Diagnostics Market Size (2015-2020)
11.2 Non-Invasive Cancer Diagnostics Key Players in India (2019-2020)
11.3 India Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
11.4 India Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Non-Invasive Cancer Diagnostics Market Size (2015-2020)
12.2 Non-Invasive Cancer Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Gen-Probe Inc
  13.1.1 Gen-Probe Inc Company Details
  13.1.2 Gen-Probe Inc Business Overview and Its Total Revenue
  13.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
  13.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020))
  13.1.5 Gen-Probe Inc Recent Development
13.2 Digene Corporation
  13.2.1 Digene Corporation Company Details
  13.2.2 Digene Corporation Business Overview and Its Total Revenue
  13.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
  13.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.2.5 Digene Corporation Recent Development
13.3 Quest Diagnostics Inc
  13.3.1 Quest Diagnostics Inc Company Details
  13.3.2 Quest Diagnostics Inc Business Overview and Its Total Revenue
  13.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
  13.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.3.5 Quest Diagnostics Inc Recent Development
13.4 Cancer, Genetics Inc
  13.4.1 Cancer, Genetics Inc Company Details
  13.4.2 Cancer, Genetics Inc Business Overview and Its Total Revenue
  13.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
  13.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.4.5 Cancer, Genetics Inc Recent Development
13.5 BIOVIEW Inc
  13.5.1 BIOVIEW Inc Company Details
  13.5.2 BIOVIEW Inc Business Overview and Its Total Revenue
  13.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
  13.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.5.5 BIOVIEW Inc Recent Development
13.6 AVIVA Biosciences Corporation
  13.6.1 AVIVA Biosciences Corporation Company Details
  13.6.2 AVIVA Biosciences Corporation Business Overview and Its Total Revenue
  13.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
  13.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.6.5 AVIVA Biosciences Corporation Recent Development
13.7 Laboratory Corporation of America Holdings (LabCorp)
  13.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
  13.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview and Its Total Revenue
  13.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
  13.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
13.8 A&G Pharmaceutical
  13.8.1 A&G Pharmaceutical Company Details
  13.8.2 A&G Pharmaceutical Business Overview and Its Total Revenue
  13.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
  13.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.8.5 A&G Pharmaceutical Recent Development
13.9 Affymetrix Inc
  13.9.1 Affymetrix Inc Company Details
  13.9.2 Affymetrix Inc Business Overview and Its Total Revenue
  13.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
  13.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.9.5 Affymetrix Inc Recent Development
13.10 Precision Therapeutics
  13.10.1 Precision Therapeutics Company Details
  13.10.2 Precision Therapeutics Business Overview and Its Total Revenue
  13.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
  13.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020)
  13.10.5 Precision Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Non-Invasive Cancer Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Invasive Cancer Diagnostics Revenue
Table 3. Ranking of Global Top Non-Invasive Cancer Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CTCs
Table 6. Key Players of CTNAS
Table 7. Key Players of Exosomes
Table 8. Global Non-Invasive Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Non-Invasive Cancer Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Non-Invasive Cancer Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2015-2020)
Table 12. Global Non-Invasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Non-Invasive Cancer Diagnostics Market Growth Strategy
Table 18. Main Points Interviewed from Key Non-Invasive Cancer Diagnostics Players
Table 19. Global Non-Invasive Cancer Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Non-Invasive Cancer Diagnostics Market Share by Players (2015-2020)
Table 21. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2019)
Table 22. Global Non-Invasive Cancer Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Non-Invasive Cancer Diagnostics Product Solution and Service
Table 25. Date of Enter into Non-Invasive Cancer Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Non-Invasive Cancer Diagnostics Market Size Share by Type (2015-2020)
Table 29. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2021-2026)
Table 30. Global Non-Invasive Cancer Diagnostics Market Size Share by Application (2015-2020)
Table 31. Global Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Non-Invasive Cancer Diagnostics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 35. North America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 37. North America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 41. Europe Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 43. Europe Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 45. China Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 47. China Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. China Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 49. China Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. China Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 51. Japan Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 53. Japan Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 55. Japan Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 59. Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 61. Southeast Asia Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 63. India Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 65. India Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. India Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 67. India Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. India Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Non-Invasive Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Non-Invasive Cancer Diagnostics Market Share (2019-2020)
Table 71. Central & South America Non-Invasive Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Non-Invasive Cancer Diagnostics Market Share by Type (2015-2020)
Table 73. Central & South America Non-Invasive Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Non-Invasive Cancer Diagnostics Market Share by Application (2015-2020)
Table 75. Gen-Probe Inc Company Details
Table 76. Gen-Probe Inc Business Overview
Table 77. Gen-Probe Inc Product
Table 78. Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 79. Gen-Probe Inc Recent Development
Table 80. Digene Corporation Company Details
Table 81. Digene Corporation Business Overview
Table 82. Digene Corporation Product
Table 83. Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 84. Digene Corporation Recent Development
Table 85. Quest Diagnostics Inc Company Details
Table 86. Quest Diagnostics Inc Business Overview
Table 87. Quest Diagnostics Inc Product
Table 88. Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 89. Quest Diagnostics Inc Recent Development
Table 90. Cancer, Genetics Inc Company Details
Table 91. Cancer, Genetics Inc Business Overview
Table 92. Cancer, Genetics Inc Product
Table 93. Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 94. Cancer, Genetics Inc Recent Development
Table 95. BIOVIEW Inc Company Details
Table 96. BIOVIEW Inc Business Overview
Table 97. BIOVIEW Inc Product
Table 98. BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 99. BIOVIEW Inc Recent Development
Table 100. AVIVA Biosciences Corporation Company Details
Table 101. AVIVA Biosciences Corporation Business Overview
Table 102. AVIVA Biosciences Corporation Product
Table 103. AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 104. AVIVA Biosciences Corporation Recent Development
Table 105. Laboratory Corporation of America Holdings (LabCorp) Company Details
Table 106. Laboratory Corporation of America Holdings (LabCorp) Business Overview
Table 107. Laboratory Corporation of America Holdings (LabCorp) Product
Table 108. Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 109. Laboratory Corporation of America Holdings (LabCorp) Recent Development
Table 110. A&G Pharmaceutical Business Overview
Table 111. A&G Pharmaceutical Product
Table 112. A&G Pharmaceutical Company Details
Table 113. A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 114. A&G Pharmaceutical Recent Development
Table 115. Affymetrix Inc Company Details
Table 116. Affymetrix Inc Business Overview
Table 117. Affymetrix Inc Product
Table 118. Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 119. Affymetrix Inc Recent Development
Table 120. Precision Therapeutics Company Details
Table 121. Precision Therapeutics Business Overview
Table 122. Precision Therapeutics Product
Table 123. Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2015-2020) (Million US$)
Table 124. Precision Therapeutics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Non-Invasive Cancer Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTCs Features
Figure 3. CTNAS Features
Figure 4. Exosomes Features
Figure 5. Global Non-Invasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Blood Case Studies
Figure 7. Urine Case Studies
Figure 8. Saliva Case Studies
Figure 9. Non-Invasive Cancer Diagnostics Report Years Considered
Figure 10. Global Non-Invasive Cancer Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Non-Invasive Cancer Diagnostics Market Share by Regions: 2020 VS 2026
Figure 12. Global Non-Invasive Cancer Diagnostics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Non-Invasive Cancer Diagnostics Market Share by Players in 2019
Figure 15. Global Top Non-Invasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Non-Invasive Cancer Diagnostics Revenue in 2019
Figure 17. North America Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Non-Invasive Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Gen-Probe Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Gen-Probe Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 26. Digene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Digene Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 28. Quest Diagnostics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Quest Diagnostics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 30. Cancer, Genetics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cancer, Genetics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 32. BIOVIEW Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. BIOVIEW Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 34. AVIVA Biosciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AVIVA Biosciences Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 36. Laboratory Corporation of America Holdings (LabCorp) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Laboratory Corporation of America Holdings (LabCorp) Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 38. A&G Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. A&G Pharmaceutical Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 40. Affymetrix Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Affymetrix Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 42. Precision Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Precision Therapeutics Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed